Izotropic Corporation retweeted
Early-onset breast cancer: a survivor’s story dlvr.it/TPPGKV #Conditions #OncologyHematology via @kevinmd
Izotropic Corporation retweeted
Addressing a Critical Global Health Need
Breast cancer is the most prevalent cancer among African women, with mortality rates exceeding 50% due to delayed diagnosis. Izotropic is taking a bold step to change this narrative. By establishing Izotropic Africa in Casablanca, Morocco, we are positioning our IzoView Breast CT technology at the heart of a region projected to have a $500M+ market for advanced oncology devices by 2030.
Morocco will serve as $IZO.c strategic gateway, bridging the gap to underserved markets across Africa and the GCC. The mission is clear: provide the advanced imaging necessary to lower mortality rates and improve patient outcomes where it is needed most.
Izotropic Corporation retweeted
The Roadmap to Commercialization - Izotropic Africa Partnership Details
Following the recent Letter Agreement, Izotropic Corporation $IZOZF is moving swiftly on our regional roadmap. Key operational milestones include:
Clinical Foundation: A major hospital site in Morocco is being secured in Q1 2026 for the first IzoView Breast CT installation to drive research and regulatory approvals.
Structure: A joint venture (60% BG / 40% Izotropic) designed to scale sales, marketing, and potential regional manufacturing.
Timeline: Parties are working in good faith to finalize a Formal Agreement by the region's regulatory landscape and establish a manufacturing foothold
Commitment: Izotropic has committed an initial $30K (of an estimated $120K first-year share) to jumpstart operations and clinical data collection.
This partnership combines Izotropic’s technical innovation with local expertise to navigate regulatory landscapes and establish a manufacturing foothold in the region.
LINK: izocorp.com/news-releases/iz…
Izotropic Corporation retweeted
Izotropic Corp. Expands Global Footprint into Africa and Middle East
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) is pleased to announce it has signed a Letter Agreement to establish Izotropic Africa, a new entity based in Casablanca, Morocco.
Partnering with an established business group, this strategic move aims to bring IzoView Breast CT technology to two high-growth regions: all of Africa and the Gulf Cooperation Council (GCC)- including Saudi Arabia, the UAE, Qatar, Kuwait, Bahrain, and Oman.
Izotropic Corporation retweeted
Take home message:
"AI-CAD identified some breast cancers missed by radiologists but failed to detect others recalled by radiologists. Careful implementation & strategic interpretation of AI-CAD are essential in mammographic screening"
pubs.rsna.org/doi/10.1148/ry…
@Radiology_AI
Izotropic Corporation retweeted
How does IzoView Breast CT work?
IzoView is a next-generation breast CT imaging system that delivers high-resolution, 360-degree images of the breast in its natural, uncompressed shape. The patient lies face-down on a padded tabletop, placing their breast through an opening into the imaging chamber. The device performs a radiation-free pre-scan to calculate a customized radiation dose tailored to each patient's unique breast. The imaging scan is then performed: IzoView's imaging hardware rotates around the breast in a full circle and captures up to 500 ultra-high-resolution images in under 10 seconds, depending on breast length. The software then reconstructs a 3D volume in approximately 30 seconds—with no need for manual positioning or breast compression.
#FAQ #Technology #Education #HowStuffWorks #Izotropic #IzoView #BreastCT #BreastCancer #MedicalDevices #MedTech #WomensHealth #Innovation $IZO $IZOZF
IzoView is not yet approved for sale.
Izotropic Corporation retweeted
Innovation worth paying attention to. 🎯
Our client @Izotropic (OTCQB: $IZOZF ) just dropped Episode 2 of their podcast series, and it’s a deep dive into how AI is revolutionizing breast imaging.
From proprietary machine-learning algorithms to exclusive CADx patent rights, they’re building technology that could change how we detect breast cancer.
This is the kind of healthcare innovation that deserves a bigger spotlight.
Today, we released Episode #2 of our podcast series: "AI and the Future of Breast Imaging: How Izotropic is Leading the Innovation."
In this episode, we explore how our AI integrations are transforming breast CT imaging—and how our proprietary reconstruction algorithm and exclusive CADx patent are setting new standards in image quality, efficiency, and clinical utility.
🔍 Available in English, Arabic, Chinese, French, German, Italian, and Spanish!
🎧 Listen now on our YouTube Channel: youtube.com/@izotropic
#Izotropic #Podcast #BreastImaging #BreastCancerScreening #BreastCancer #EarlyDetectionSavesLives #MedicalImaging #HealthTech #IzoView #BreastCT #RadiologyInnovation #WomensHealth #AIinHealthcare #MedTech #ImagingAI #InvestorPodcast $IZO $IZOZF
Izotropic Corporation retweeted
The future of breast cancer detection isn’t just about better images; it’s about smarter technology.
In Episode 2 of Izotropic’s podcast series, discover how AI is transforming breast imaging from the ground up. From proprietary machine-learning algorithms to exclusive CADx patent rights, Izotropic is building the next generation of diagnostic tools.
#BreastHealth
🎧 Listen now:
youtu.be/xXJPKf2wH8o?si=A74S…
Izotropic Corporation retweeted
What clinical problem is IzoView designed to solve?
IzoView is designed to solve the long-standing limitations of current breast imaging technologies, especially for women with dense breast tissue. Mammography and digital breast tomosynthesis ("DBT") rely on breast compression, which can distort anatomy and obscure cancers. MRI is expensive, time-consuming, and inaccessible to many patients. IzoView eliminates compression and delivers true 3D breast imaging that may enhance visibility, accuracy, and diagnostic confidence while reducing patient discomfort.
🤖 Made with AI
Izotropic Corporation retweeted
$IZO.c / $IZOZF is targeting one of the biggest unmet needs in breast cancer screening:
dense breast tissue, which affects ~50% of women and reduces the effectiveness of standard tools like mammography and DBT.
IzoView is being developed as a dedicated Breast CT system:
“True 3D imaging, no compression, ~500 high-res images in ~10 seconds.”
“Intended for use alongside DBT in asymptomatic women with dense breast tissue.”
With a $500K target device price, IzoView is designed for broad clinical access, not just elite hospitals.
Positioned between DBT and MRI, this platform could help reshape how early cancers are found.
@ChupaPlata @EvoluxCapital
Izotropic Corporation retweeted
This month, we recognize the millions impacted by breast cancer — and we stay focused on developing technologies that could one day support earlier detection and better care.
🔗 izocorp.com
IzoView has not yet been approved or cleared for sale. Forward-looking statements apply.
Izotropic Corporation retweeted
October is Breast Cancer Awareness Month.
Izotropic ( IZO.c / IZOZF) is marking it with an important update — highlighting why many women are still underserved by today’s screening tools and how IzoView is being developed to help fill that gap.
Izotropic Corporation retweeted
Dense breast tissue remains one of the biggest challenges in screening, and we're focused on developing IzoView to address this exact need.
$IZO.cn $IZOZF
#MedicalDevices #CEMark #RegulatoryStrategy #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #AIinHealthcare #InvestorNews #IzoView #Izotropic
Izotropic Corporation retweeted
Breast cancer remains the #1 diagnosed cancer in women worldwide, with 2.3M+ new cases each year.
In the U.S. alone, over 315,000 women are expected to be diagnosed in 2025 — almost 1 in 3 new cancer cases in women.
The need for better imaging tools is urgent.
#MedicalDevices #CEMark #RegulatoryStrategy #MedicalImaging #Radiology #BreastCancerAwareness #HealthTech #DigitalHealth #AIinHealthcare #InvestorNews #IzoView #Izotropic
Izotropic Corporation retweeted
$IZO.cn / $IZOZF update for Breast Cancer Awareness Month.
The update breaks down gaps in current screening tools, especially for women with dense breast tissue — and explains how IzoView is being developed to help fill that gap.
“True 3D imaging, no compression, ~500 high-res images in ~10 seconds.”
“Aimed at bridging the gap between DBT and MRI.”
Izotropic Corporation retweeted
Breast density can play a role in cancer risk. Here’s how to know if it impacts you. ➡️ spr.ly/6017AUFM1 #BreastCancerAwarenessMonth
Izotropic Corporation retweeted
🏥 Medical imaging should be advanced — but also practical.
IzoView is self-shielded and modular, meaning it can be installed in virtually any clinical setting without the need for costly lead-lined rooms or major construction.
That means:
Faster deployment in imaging centers
Lower setup and facility costs
Easier access for patients, everywhere
Smart engineering that lowers barriers — and expands access.
#BreastImaging #MedicalDevices #HealthcareInnovation #MedTech $IZO $IZOZF
Izotropic Corporation retweeted
Izotropic (CSE: IZO / OTCQB: IZOZF) is advancing IzoView, a dedicated Breast CT platform currently in development.
• “True 3D imaging”
• “Compression-free design”
• “Engineered for patients with dense breast tissue”
• “Modular, self-shielded system designed for clinical environments”
Momentum is building as IzoView moves toward its pivotal U.S.-based clinical study.
— Evolux Capital (Client: Izotropic Corp.)
IzoView has not yet been approved or cleared for sale. Forward-looking statements apply.
Izotropic Corporation retweeted
🧠 Artificial intelligence is reshaping medical imaging — and IzoView is leading the shift in breast CT. IzoView’s proprietary AI denoising algorithm improves image quality without increasing radiation dose.
That means:
Cleaner, sharper images for radiologists
Preserved fine anatomical details
Safer, low-dose scans for patients
A smarter way to deliver precision — with safety built in.
#BreastCT #RadiologyAI #BreastImaging #MedTechInnovation $IZO $IZOZF
